These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 25744783)
1. Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease. Yamashita T; Sasaki N; Kasahara K; Hirata K J Cardiol; 2015 Jul; 66(1):1-8. PubMed ID: 25744783 [TBL] [Abstract][Full Text] [Related]
2. Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response. Chistiakov DA; Sobenin IA; Orekhov AN Immunol Lett; 2013 Mar; 151(1-2):10-22. PubMed ID: 23411158 [TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory Strategies in Atherosclerosis. Bugger H; Zirlik A Hamostaseologie; 2021 Dec; 41(6):433-442. PubMed ID: 34942656 [TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells in atherogenesis. Sasaki N; Yamashita T; Takeda M; Hirata K J Atheroscler Thromb; 2012; 19(6):503-15. PubMed ID: 22498766 [TBL] [Abstract][Full Text] [Related]
5. Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis - a review of the experimental evidence. Björkbacka H; Fredrikson GN; Nilsson J Atherosclerosis; 2013 Mar; 227(1):9-17. PubMed ID: 23177975 [TBL] [Abstract][Full Text] [Related]
7. T cell-based therapies for atherosclerosis. Ketelhuth DF; Gisterå A; Johansson DK; Hansson GK Curr Pharm Des; 2013; 19(33):5850-8. PubMed ID: 23438952 [TBL] [Abstract][Full Text] [Related]
8. Dendritic cells in atherogenesis: possible novel targets for prevention of atherosclerosis. Takeda M; Yamashita T; Sasaki N; Hirata K J Atheroscler Thromb; 2012; 19(11):953-61. PubMed ID: 22878702 [TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells and tolerogenic dendritic cells as critical immune modulators in atherogenesis. Sasaki N; Yamashita T; Kasahara K; Takeda M; Hirata K Curr Pharm Des; 2015; 21(9):1107-17. PubMed ID: 25312730 [TBL] [Abstract][Full Text] [Related]
10. Oral Tolerization with Mycobacterial Heat Shock Protein 65 Reduces Chronic Experimental Atherosclerosis in Aged Mice. Wick C; Onestingel E; Demetz E; Dietrich H; Wick G Gerontology; 2018; 64(1):36-48. PubMed ID: 28910785 [TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory and Immunomodulatory Therapies in Atherosclerosis. Deroissart J; Porsch F; Koller T; Binder CJ Handb Exp Pharmacol; 2022; 270():359-404. PubMed ID: 34251531 [TBL] [Abstract][Full Text] [Related]
12. Novel directions in inflammation as a therapeutic target in atherosclerosis. Verweij SL; van der Valk FM; Stroes ES Curr Opin Lipidol; 2015 Dec; 26(6):580-5. PubMed ID: 26382552 [TBL] [Abstract][Full Text] [Related]
13. Opportunities for an atherosclerosis vaccine: From mice to humans. Roy P; Ali AJ; Kobiyama K; Ghosheh Y; Ley K Vaccine; 2020 Jun; 38(28):4495-4506. PubMed ID: 31964554 [TBL] [Abstract][Full Text] [Related]